




Abstract— We propose WELCOME, an innovative integrated 
care platform using wearable sensors and smart cloud 
computing for Chronic Obstructive Pulmonary Disease 
(COPD) patients with co-morbidities. WELCOME aims to 
bring about a change in the reactive nature of the management 
of chronic diseases and its comorbidities, in particular through 
the development of a patient centred and proactive approach to 
COPD management. The aim of WELCOME is to support 
healthcare services to give early detection of complications 
(potentially reducing hospitalisations) and the prevention and 
mitigation of comorbidities (Heart Failure, Diabetes, Anxiety 
and Depression). The system incorporates patient hub, where it 
interacts with the patient via a light vest including a large 
number of non-invasive chest sensors for monitoring various 
relevant parameters. In addition, interactive applications to 
monitor and manage diabetes, anxiety and lifestyle issues will 
be provided to the patient. Informal carers will also be 
supported in dealing with their patients. On the other hand, 
welcome smart cloud platform is the heart of the proposed 
system where all the medical records and the monitoring data 
are managed and processed via the decision support system. 
Healthcare professionals will be able to securely access the 
WELCOME applications to monitor and manage the patient’s 
conditions and respond to alerts on personalized level.  
I.  INTRODUCTION  
COPD (Chronic Obstructive Pulmonary Disease) is a 
common preventable and treatable disease, characterized by 
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persistent airflow limitation that is usually progressive and 
associated with an enhanced chronic inflammatory response 
in the airways and the lung to noxious particles or gases. 
Exacerbations and comorbidities contribute to the overall 
severity in individual patients. 
COPD poses a significant public health burden with a 
morbidity and mortality rate that is increasing. One WHO 
report anticipates that by 2030, COPD will become the fourth 
cause of mortality and seventh cause of morbidity worldwide 
[1]. The prevalence of COPD in Europe ranges from 3.5% to 
14%. However, in its report the WHO maintains that this an 
underestimation as estimates via spirometry were higher than 
those estimated using methods based on symptoms. 
The successful management of COPD patients requires a 
multidisciplinary approach. Pharmacological treatment of 
patients with mild COPD should be initiated using a short-
acting bronchodilator (β2 agonist or anticholinergic). A long-
acting bronchodilator is added in patients with moderate 
COPD. Treatment with inhaled corticosteroids is needed in 
patients with severe COPD. Other aspects of treatment 
include vaccinations, antibiotics, mucolytics etc. In the late-
stage of severity long-term oxygen therapy, non-invasive 
ventilation and surgical treatment become necessary. An 
important aspect of COPD management is maintaining 
adherence and proper inhaler technique. 
Non-pharmacological treatment is also important and it 
includes; pulmonary rehabilitation and exercise 
(physiotherapy), nutritional assessments and smoking 
cessation. The latter has been shown to reduce disease 
progression, exacerbations, hospital admissions and mortality 
rate. This is supported by several studies. Despite its proven 
positive impact, smoking cessation is hard to achieve in 
clinical practice. This has been linked to co-existing addiction 
(ex-alcohol) and psychiatric diseases which reduce success 
rates and consequently increase mortality. In addition, 
exposure to pollution and chemicals may have an adverse 
effect on COPD management. A recent EU funded study [2], 
examined the distribution of various ambient particle metrics 
in four European cities and the results revealed a correlation 
between course particle concentration and COPD symptoms.  
COPD is often associated with several co-morbidities 
such as cardiovascular disease (such as congestive heart 
failure-CHF), metabolic syndrome (including diabetes), 
osteoporosis, mental health diseases (depression and anxiety) 
and lung cancer. The most frequent chronic diseases often 
develop together. Comorbidities markedly affect health 
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outcomes in COPD; in fact, patients with COPD mainly die 
of non-respiratory diseases [3], such as cardiovascular 
diseases (25%), cancer (mainly lung cancer, 20–33%) and 
other causes (30%). 
WELCOME is an innovative system that goes beyond the 
state of the art though: a) Integrated care encompassing 
socio-medical aspects and technology of monitoring and 
treatment of COPD patients with comorbidities of CHF, 
diabetes, anxiety and depression, b) Technological elements, 
like sensing components and microelectronics that will 
compose system’s motoring devices, c) Cloud services and 
advanced content delivery that will lead to an integrated 
healthcare approach than can be adopted to different 
countries, and d) Unified content delivery to a variety of 
devices (mobile and stationary) implemented in software 
applications with intuitive user interfaces provided to all 
actors involved in the therapy line. 
II. INTEGRATED CARE APPROACH AND COUNTRIES 
SCENARIOS  
A. Integrated Care Approach 
The concept of integrated care has been introduced into 
the management of various disease states. It supports the 
implementation and incorporation of multiple types of 
interventions in the patient care pathway. These might 
include patient related (patient education, self-management), 
professional directed (Provider education, re-distribution of 
roles: e.g. expanding the role of the pharmacist) and/or 
organizational (continuity of care, case management, follow 
up, use of information and communication technology) 
interventions. In COPD, current evidence from a systematic 
review of integrated disease management programs shows 
improvements in quality of life and reductions in 
hospitalisations in triple interventions [4]. 
Moreover, the use of ICT in such successful integrated 
care models has been evident in several studies. One study 
evaluated the effect of integrated care (IC) on COPD patients 
as compared to usual care (UC). The IC model included a 
comprehensive assessment of the patient (adherence, 
comorbidities, severity etc.), patient education, individualized 
care with follow up and a 24 hour access to care via an 
information and ICT platform. One hundred and thirteen 
patients were recruited and randomised to 2 groups IC and 
UC. After 12 months, the IC group had improved nutritional 
status and self-management scores which included 
(knowledge, exacerbation identification, inhaler adherence 
and correctness). These factors translated into a reduced 
hospital re-admission rate [5]. 
B. Countries Scenarios 
The WELCOME system will be tested in five countries 
with different health-care systems (Germany, Greece, UK, 
Netherlands and Ireland), in order to be evaluated in terms of 
feasibility, acceptance and impact as a treating tool, with the 
appropriate contextualisation required for each pilot country.  
A major concern for the development such system is the 
unified handling of the treatment processes followed in the 
different countries participating in the project. A mapping of 
the patient care pathways followed in the countries 
participating in the project has started in order to identify 
differences or possible contradictions. The WELCOME 
system will implement different user scenarios for each 
country, adapted to its own patient care pathways. The 
definition of these scenarios is part of the ongoing system 
requirements process. 
As a use case scenario of the WELCOME system, figure 
1.b shows the WELCOME system as part of the current 
healthcare pathway for COPD patient in UK. The care 
pathway for COPD patients start at the GP in UK, the follow 
up is provided by GP visits, community services, hospital 
chest clinics and special clinical teams [6]. The follow-up 
care services involve GP, consultants, physiotherapist and 
nurses. The special clinical team includes the respiratory 
teams and community matrons providing specialist input and 
basic support including respiratory teams’ clinics, pulmonary 
rehabilitation and smoking cessation.  
 
Figure 1.  a) Integrated care concepts in WELCOME, b) WELCOME 
System – UK use case scenario 
III. SYSTEM ARCHITECTURE 
Figure 2 shows the architecture of the welcome system 
demonstrating the functional modules of the system and 









in a highly modular fashion in order to ease its development 
and task distribution between the partners.  
The cloud part of the system consists of several modules 
(storage server, feature extraction module, decision support 
system and external applications connector). Patient hub 
handles the interaction with the patient and the transfer of the 
patient’s biosignals. WELCOME applications interact with 
the medical staff and facilitate the comorbidities treatment. 
The functionality described in this section is currently refined 
during the ongoing process of the system requirements. 
A. WELCOME patient Hub 
Welcome patient hub includes all the software and 
hardware components interacting with the patient, including: 
a) a unified data acquisition application to collect the medical 
data from the medical sensors and submit those data to the 
WELCOME cloud, and b) interactive applications to collect 
information and present the results including alarms, 
motivation messages, and guidelines for the patient in 
intuitive ways with a capability of providing feedback, etc.  
The patient sensor system is built around a light vest 
including a large number of standalone non-invasive chest 
sensors for   measuring and monitoring various parameters of 
COPD and co-morbidities. It incorporates 26 sensors 
connected together via a two-wire bus Body Area network, 
working in concert for measuring and monitoring various 
parameters of COPD and co-morbidities. More specifically, 
the vital signs and parameters to be measured include: a)  
SpO2: lowering below a predefined threshold (usually 90%) 
is a concern, b) EIT: Electrical Impedance Tomography 
findings consistent with increased degree of ventilation 
heterogeneity associated with exacerbation of COPD, 
inadequate therapy or natural progression of the disease, 
pulmonary oedema and/or pleural effusion (especially in the 
COPD and CHF subgroups), c) Chest sounds: crackles, 
rhonchi or wheezing, d) Multichannel electrocardiogram 
(ECG): onset of a not previously reported tachycardia or 
arrhythmia like atrial fibrillation, e) activity. For patients with 
comorbidity like diabetes and inhaler adherence problems, 
the patient hub incorporates the diabetes kit (including the 
Glucose meter, Blood pressure meter and Weight scale) in 
addition to the Dry powder inhaler (figure 1b).   
Transferring medical data of such volume to the cloud is 
not a trivial task. Many considerations regarding bandwidth 
efficiency and security rise through the current ongoing 
design process. Following standardized security/privacy 
procedures (anonymizing data, securing network, etc.) adds 
valued overhead and therefore compression techniques are 
engaged before transmitting data to the cloud. The wireless 
communications of all Patient Hub components with the rest 
of the system will be reflected to the communication APIs. 
According to the WELCOME system design, the patient 
hub platform is a software application that can be 
implemented on portable devices (e.g. android or windows 
mobile), and collects the vest data via the Wifi short range 
communication, the Diabetes sensors via the Bluetooth 
communications and the inhaler adherence data via the USB 
connectivity. In this Personal Area Network based structure 
of the patient hub, data gets aggregated and processed in the 
patient hub platform and once ready gets transmitted to the 
cloud via the mobile communication network or the 
Broadband home communications network.   
B. WELCOME Cloud  
The welcome cloud system consists of three main parts, 
the storage server, the feature extraction module and the 
decision support system (DSS). These modules handle the 
medical data provided by the end users, after anonymization 
in order to ensure data privacy. The workflow of data and 
the system’s activities is coordinated by an orchestrator 
software agent who will handle the communication between 
the various system’s sub-modules and trigger the DSS. 
 
 
Figure 2.  WELCOME high level system architecture 
The storage server saves the patient data, biosignals and 
bioparameters coming from the patient hub and medically 
relevant data coming from the patient’s evaluation by 
medical staff. It should be noted that the storage server does 
not save data regarding the applications’ realm (user data, 
etc.) but only data having to do with the patient’s medical 
condition. Monitoring of such multiparameter signals leads to 
a large and complex data set to be stored. Therefore, the 
storage server will face the big data challenge, in terms of 
maintenance and performance [7]. 
The feature extraction module retrieves from the storage 
the raw signals originating from the patient hub (ECG, EIT, 
lung sounds, etc.). The module extracts several higher level 
features, for example the occurrence of crackles, to be used in 
the decision process [8].  
WELCOME decision support system (DSS) will engage 
semantic web technologies and dynamic rules to enhance the 
inference process [9]. The outcome of the decision support 
procedure will be alarms, warnings and estimations regarding 
the patient’s status based on patients’ clinical data, biosignal 
data and extracted features. The definition of the rule set is 
one of the main parts of the currently ongoing system’s 
requirements definition process. The definition of the specific 
rule set is far from trivial as it will engage multidisciplinary 
medical rules, potentially contradicting, for treatment of 
COPD multimorbid patients. 
The WELCOME cloud system will communicate with 
the rest of the system’s parts using standardized and secure 






REST services inside a VPN accessed through certified 
router devices from user side. 
C.  WELCOME Healthcare Applications 
 The healthcare applications handle the interaction of the 
users with the system. The system’s user roles are the 
patients, the medical personnel, the patient’s informal carers 
(e.g. family) and the system’s administrators. During the 
ongoing design phase, we organize the applications mainly in 
two groups: the applications running on the patient hub and 
the applications provided as services through a unified 
platform. The content of the applications will be accessible 
from both stationary (PCs, desktops) and mobile devices 
(tablets, smartphones). Patient hub applications will be 
available on the patient’s home infrastructure and mainly 
interact with the patient. One such application is the lifestyle 
application which will monitor the patient’s lifestyle and 
provide related advice and support [6], e.g. on smoking 
cessation and physical activity. The informal carer 
application will be used to access the patient’s medical 
information, history and schedule in order to help the 
informal carers in their everyday care of the patient. 
The platform services will be accessed through a secure 
network infrastructure and standardized control access 
mechanisms. The provided functionality will depend on the 
specific user’s permissions and will include administration 
tasks, clinical evaluation applications, visualizing of patient’s 
biosignals and patient’s behavioural/lifestyle assessment. 
They will be adjustable to local Healthcare needs, for 
providing integrated care services. On these applications’ 
design, we emphasize on the need of coordinated care of the 
COPD and the respective comorbidities. 
IV. STANDARDIZATION AND LEGAL ISSUES 
WELCOME system includes non-intrusive electronic 
equipment, a clinical decision support system and 
management of sensitive personal data. Issues of legal 
regulation and standardization rise for such systems. Despite 
the fact that WELCOME is research oriented and not a 
production system, we design its development taking into 
account the most commonly accepted standards, guidelines 
and relevant best practices in the domains of network 
communications infrastructure, data model, user interaction 
and security, including HL7, ISO, HIPAA and CEN. More 
specifically, we plan to integrate the EPSOS Patient 
Summary and ePrescription data model concepts [10] in our 
system (keeping in mind that concepts of patient information 
may be compatible but the information flow may differ in 
EPSOS) and also implement HL7 specifications for 
interoperable resources [11], as well as apply 
pseudonymization techniques (ISO/TS 25237) for the 
protection of personal sensitive data. Moreover, we 
investigate the Continua Alliance guidelines for sensor 
communication and decided to implement https RESTful 
services for our network communications [12, 13]. Regarding 
our overall development lifecycle, we decided to follow the 
ANSI IEC 62304:2006 standard which relates to the medical 
software lifecycle processes and ISO 14971 for the risk 
management of our system [14]. 
V. CONCLUSION AND DISCUSSION 
Many integrated care approaches were reported in 
literature [15]. These approaches can be classified based on 
the implementation degree on the healthcare hierarchy levels, 
including System, Organisational, Functional, Professional, 
Service and Personal level. The WELCOME system will 
target the Functional level (as an ICT platform), the personal 
level (as a patient’s and informal carer centric platform), 
Service level (bringing healthcare and social care together), 
Professional level (requires the cooperation and the 
communication of the different Healthcare professionals 
responsible for the COPD patients and other co-morbidities).   
Currently the project is on the requirements gathering and 
design phase. We have already identified some major issues 
of implementing this big and complex system. Integrating 
such a multi-parametric monitoring system with enhanced 
data management and decision support concepts is far from 
trivial. However, the difficulties are not only technical, but 
most importantly conceptual as the project intends to unify 
the treatment of COPD with its comorbidities in order to 
present a new approach in the medical practice, taking into 
account contextualisation for each healthcare system. 
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